sample	O	O	
type	O	O	
/	O	O	
medical	O	O	
specialty	O	O	
:	O	O	
general	O	O	
medicine	O	O	
sample	O	O	
name	O	O	
:	O	O	
hyperthyroidism	O	O	
following	O	O	
pregnancy	O	O	
description	O	O	
:	O	O	
chief	O	O	
complaint	O	O	
of	O	O	
chest	O	O	
pain	O	O	
,	O	O	
previously	O	O	
diagnosed	O	O	
with	O	O	
hyperthyroidism	O	O	
.	O	O	
(	O	O	
medical	O	O	
transcription	O	O	
sample	O	O	
report	O	O	
)	O	O	
history	O	O	hpi-s
:	O	O	
patient	O	O	
is	O	O	
a	O	O	
21	O	O	
-	O	O	
year	O	O	
-	O	O	
old	O	O	
white	O	O	
woman	O	O	
who	O	O	
presented	O	O	
with	O	O	
a	O	O	
chief	O	O	
complaint	O	O	
of	O	O	
chest	B-cc	B-cc	
pain	I-cc	I-cc	
.	O	O	
she	O	O	
had	O	O	
been	O	O	
previously	O	O	
diagnosed	O	O	
with	O	O	
hyperthyroidism	O	B-pastHistory	
.	O	O	
upon	O	O	
admission	O	O	
,	O	O	
she	O	O	
had	O	O	
complaints	O	O	
of	O	O	
constant	B-hpi.timing	B-hpi.timing	
left	B-hpi.location	B-hpi.location	
sided	I-hpi.location	I-hpi.location	
chest	I-hpi.location	I-hpi.location	
pain	I-cc	O	
that	O	O	
radiated	B-hpi.assocSignsAndSymptoms	B-hpi.assocSignsAndSymptoms	
to	I-hpi.location	I-hpi.assocSignsAndSymptoms	
her	I-hpi.location	I-hpi.assocSignsAndSymptoms	
left	I-hpi.location	I-hpi.assocSignsAndSymptoms	
arm	I-hpi.location	I-hpi.assocSignsAndSymptoms	
.	O	O	
she	O	O	
had	O	O	
been	O	O	
experiencing	O	O	
palpitations	B-hpi.assocSignsAndSymptoms	B-hpi.assocSignsAndSymptoms	
and	O	O	
tachycardia	B-hpi.assocSignsAndSymptoms	B-hpi.assocSignsAndSymptoms	
.	O	O	
she	O	O	
had	O	O	
no	O	O	
diaphoresis	O	O	
,	O	O	
no	O	O	
nausea	O	O	
,	O	O	
vomiting	O	O	
,	O	O	
or	O	O	
dyspnea	O	O	
.	O	O	
she	O	O	
had	O	O	
a	O	O	
significant	O	O	
tsh	B-hpi.assocSignsAndSymptoms	O	
of	I-hpi.assocSignsAndSymptoms	O	
0	I-hpi.assocSignsAndSymptoms	O	
.	O	O	
004	I-hpi.assocSignsAndSymptoms	O	
and	O	O	
a	O	O	
free	B-hpi.assocSignsAndSymptoms	O	
t4	I-hpi.assocSignsAndSymptoms	O	
of	I-hpi.assocSignsAndSymptoms	O	
19	I-hpi.assocSignsAndSymptoms	O	
.	I-hpi.assocSignsAndSymptoms	O	
3	I-hpi.assocSignsAndSymptoms	O	
.	O	O	
normal	O	O	
ranges	O	O	
for	O	O	
tsh	O	O	
and	O	O	
free	O	O	
t4	O	O	
are	O	O	
0	O	O	
.	O	O	
5	O	O	
-	O	O	
4	O	O	
.	O	O	
7	O	O	
&	O	O	
micro	O	O	
;	O	O	
iu	O	O	
/	O	O	
ml	O	O	
and	O	O	
0	O	O	
.	O	O	
8	O	O	
-	O	O	
1	O	O	
.	O	O	
8	O	O	
ng	O	O	
/	O	O	
dl	O	O	
,	O	O	
respectively	O	O	
.	O	O	
her	O	O	
symptoms	O	O	
started	O	O	
four	B-hpi.duration	O	
months	I-hpi.duration	O	
into	I-hpi.duration	O	
her	O	O	
pregnancy	O	O	
as	O	O	
tremors	B-cc	B-hpi.assocSignsAndSymptoms	
,	O	O	
hot	B-cc	B-hpi.assocSignsAndSymptoms	
flashes	I-cc	I-hpi.assocSignsAndSymptoms	
,	O	O	
agitation	B-hpi.assocSignsAndSymptoms	B-hpi.assocSignsAndSymptoms	
,	O	O	
and	O	O	
emotional	B-hpi.assocSignsAndSymptoms	B-hpi.assocSignsAndSymptoms	
inconsistency	I-hpi.assocSignsAndSymptoms	I-hpi.assocSignsAndSymptoms	
.	O	O	
she	O	O	
gained	B-socialHistory	O	
16	O	O	
pounds	O	O	
during	O	O	
her	O	O	
pregnancy	O	B-socialHistory	
and	O	O	
has	O	O	
lost	O	B-hpi.assocSignsAndSymptoms	
80	O	I-hpi.assocSignsAndSymptoms	
pounds	O	I-hpi.assocSignsAndSymptoms	
afterwards	O	I-hpi.assocSignsAndSymptoms	
.	O	O	
she	O	O	
complained	O	O	
of	O	O	
sweating	O	B-hpi.assocSignsAndSymptoms	
,	O	O	
but	O	O	
has	O	O	
experienced	O	O	
no	O	O	
diarrhea	O	O	
and	O	O	
no	O	O	
change	O	O	
in	O	O	
appetite	O	O	
.	O	O	
she	O	O	
was	O	O	
given	O	O	
isosorbide	B-hpi.modifyingFactors	B-hpi.modifyingFactors	
mononitrate	I-hpi.modifyingFactors	I-hpi.modifyingFactors	
and	O	O	
iv	B-hpi.modifyingFactors	B-hpi.modifyingFactors	
steroids	I-hpi.modifyingFactors	I-hpi.modifyingFactors	
in	O	O	
the	O	O	
er	O	O	
.	O	O	hpi-t
family	O	O	fh-s
history	O	O	
:	O	O	
diabetes	B-familyHistory	B-familyHistory	
,	O	O	
hypertension	B-familyHistory	B-familyHistory	
,	O	O	
father	O	O	
had	O	O	
a	O	O	
coronary	B-familyHistory	B-familyHistory	
artery	I-familyHistory	I-familyHistory	
bypass	I-familyHistory	I-familyHistory	
graph	I-familyHistory	I-familyHistory	
(	O	I-familyHistory	
cabg	O	I-familyHistory	
)	O	I-familyHistory	
at	O	O	
age	O	O	
34	O	O	
.	O	O	fh-t
social	O	O	sh-s
history	O	O	
:	O	O	
she	O	O	
had	B-socialHistory	B-socialHistory	
a	I-socialHistory	I-socialHistory	
baby	I-socialHistory	I-socialHistory	
five	I-socialHistory	I-socialHistory	
months	I-socialHistory	I-socialHistory	
ago	I-socialHistory	I-socialHistory	
.	O	O	
she	O	O	
smokes	B-socialHistory	B-socialHistory	
a	I-socialHistory	I-socialHistory	
half	I-socialHistory	I-socialHistory	
pack	I-socialHistory	I-socialHistory	
a	I-socialHistory	I-socialHistory	
day	I-socialHistory	I-socialHistory	
.	O	O	
she	O	O	
denies	B-socialHistory	B-socialHistory	
alcohol	I-socialHistory	I-socialHistory	
and	I-socialHistory	I-socialHistory	
drug	I-socialHistory	I-socialHistory	
use	I-socialHistory	I-socialHistory	
.	O	O	sh-t
medications	O	O	ph-s
:	O	O	
citalopram	B-pastHistory	B-pastHistory	
10mg	O	O	
once	O	O	
daily	O	O	
for	O	O	
depression	B-pastHistory	O	
;	O	O	
low	B-pastHistory	O	
dose	O	O	
tramadol	B-pastHistory	B-pastHistory	
prn	O	I-pastHistory	
pain	O	O	
.	O	O	ph-t
physical	O	O	
examination	O	O	
:	O	O	
temperature	O	O	
98	O	O	
.	O	O	
4	O	O	
;	O	O	
pulse	O	O	
123	O	O	
;	O	O	
respiratory	O	O	
rate	O	O	
16	O	O	
;	O	O	
blood	O	O	
pressure	O	O	
143	O	O	
/	O	O	
74	O	O	
.	O	O	
heent	O	O	
:	O	O	
she	O	O	
has	O	O	
exophthalmos	O	O	
and	O	O	
could	O	O	
not	O	O	
close	O	O	
her	O	O	
lids	O	O	
completely	O	O	
.	O	O	
cardiovascular	O	O	
:	O	O	
tachycardia	O	O	
.	O	O	
neurologic	O	O	
:	O	O	
she	O	O	
had	O	O	
mild	O	O	
hyperreflexiveness	O	O	
.	O	O	
lab	O	O	
:	O	O	
all	O	O	
labs	O	O	
within	O	O	
normal	O	O	
limits	O	O	
with	O	O	
the	O	O	
exception	O	O	
of	O	O	
sodium	O	O	
133	O	O	
,	O	O	
creatinine	O	O	
0	O	O	
.	O	O	
2	O	O	
,	O	O	
tsh	O	O	
0	O	O	
.	O	O	
004	O	O	
,	O	O	
free	O	O	
t4	O	O	
19	O	O	
.	O	O	
3	O	O	
ekg	O	O	
showed	O	O	
sinus	O	O	
tachycardia	O	O	
with	O	O	
a	O	O	
rate	O	O	
of	O	O	
122	O	O	
.	O	O	
urine	O	O	
pregnancy	O	O	
test	O	O	
was	O	O	
negative	O	O	
.	O	O	
hospital	O	O	
course	O	O	
:	O	O	
after	O	O	
admission	O	O	
,	O	O	
she	O	O	
was	O	O	
given	O	O	
propranolol	O	O	
at	O	O	
40mg	O	O	
daily	O	O	
and	O	O	
continued	O	O	
on	O	O	
telemetry	O	O	
.	O	O	
on	O	O	
the	O	O	
2nd	O	O	
day	O	O	
of	O	O	
treatment	O	O	
,	O	O	
the	O	O	
patient	O	O	
still	O	O	
complained	O	O	
of	O	O	
chest	O	O	
pain	O	O	
.	O	O	
ekg	O	O	
again	O	O	
showed	O	O	
tachycardia	O	O	
.	O	O	
propranolol	B-pastHistory	O	
was	O	O	
increased	O	O	
from	O	O	
40mg	O	O	
daily	O	O	
to	O	O	
60mg	O	O	
twice	O	O	
daily	O	O	
.	O	O	
a	O	O	
i	O	O	
-	O	O	
123	O	O	
thyroid	O	O	
uptake	O	O	
scan	O	O	
demonstrated	O	O	
an	O	O	
increased	O	O	
thyroid	O	O	
uptake	O	O	
of	O	O	
90	O	O	
%	O	O	
at	O	O	
4	O	O	
hours	O	O	
and	O	O	
94	O	O	
%	O	O	
at	O	O	
24	O	O	
hours	O	O	
.	O	O	
the	O	O	
normal	O	O	
range	O	O	
for	O	O	
4	O	O	
-	O	O	
hour	O	O	
uptake	O	O	
is	O	O	
5	O	O	
-	O	O	
15	O	O	
%	O	O	
and	O	O	
15	O	O	
-	O	O	
25	O	O	
%	O	O	
for	O	O	
24	O	O	
-	O	O	
hour	O	O	
uptake	O	O	
.	O	O	
endocrine	O	O	
consult	O	O	
recommended	O	O	
radioactive	O	O	
i	O	O	
-	O	O	
131	O	O	
for	O	O	
treatment	O	O	
of	O	O	
graves	O	O	
disease	O	O	
.	O	O	
two	O	O	
days	O	O	
later	O	O	
she	O	O	
received	O	O	
15	O	O	
.	O	O	
5mci	O	O	
of	O	O	
i	O	O	
-	O	O	
131	O	O	
.	O	O	
she	O	O	
was	O	O	
to	O	O	
return	O	O	
home	O	O	
after	O	O	
the	O	O	
iodine	O	O	
treatment	O	O	
.	O	O	
she	O	O	
was	O	O	
instructed	O	O	
to	O	O	
avoid	O	O	
contact	O	O	
with	O	O	
her	O	O	
baby	O	O	
for	O	O	
the	O	O	
next	O	O	
week	O	O	
and	O	O	
to	O	O	
cease	O	O	
breast	O	O	
feeding	O	O	
.	O	O	
assessment	O	O	
/	O	O	
plan	O	O	
:	O	O	
1	O	O	
.	O	O	
treatment	O	O	
of	O	O	
hyperthyroidism	O	O	
.	O	O	
patient	O	O	
underwent	O	O	
radioactive	O	O	
iodine	O	O	
131	O	O	
ablation	O	O	
therapy	O	O	
.	O	O	
2	O	O	
.	O	O	
management	O	O	
of	O	O	
cardiac	O	O	
symptoms	O	O	
stemming	O	O	
from	O	O	
hyperthyroidism	O	O	
.	O	O	
patient	O	O	
was	O	O	
discharged	O	O	
on	O	O	
propranolol	O	O	
60mg	O	O	
,	O	O	
one	O	O	
tablet	O	O	
twice	O	O	
daily	O	O	
.	O	O	
3	O	O	
.	O	O	
monitor	O	O	
patient	O	O	
for	O	O	
complications	O	O	
of	O	O	
i	O	O	
-	O	O	
131	O	O	
therapy	O	O	
such	O	O	
as	O	O	
hypothyroidism	O	O	
.	O	O	
she	O	O	
should	O	O	
return	O	O	
to	O	O	
endocrine	O	O	
clinic	O	O	
in	O	O	
six	O	O	
weeks	O	O	
to	O	O	
have	O	O	
thyroid	O	O	
function	O	O	
tests	O	O	
performed	O	O	
.	O	O	
long	O	O	
-	O	O	
term	O	O	
follow	O	O	
-	O	O	
up	O	O	
includes	O	O	
thyroid	O	O	
function	O	O	
tests	O	O	
at	O	O	
6	O	O	
-	O	O	
12	O	O	
month	O	O	
intervals	O	O	
.	O	O	
4	O	O	
.	O	O	
prevention	O	O	
of	O	O	
pregnancy	O	O	
for	O	O	
one	O	O	
year	O	O	
post	O	O	
i	O	O	
-	O	O	
131	O	O	
therapy	O	O	
.	O	O	
patient	O	O	
was	O	O	
instructed	O	O	
to	O	O	
use	O	O	
2	O	O	
forms	O	O	
of	O	O	
birth	O	O	
control	O	O	
and	O	O	
was	O	O	
discharged	O	O	
an	O	O	
oral	O	O	
contraceptive	O	O	
,	O	O	
taken	O	O	
one	O	O	
tablet	O	O	
daily	O	O	
.	O	O	
5	O	O	
.	O	O	
monitor	O	O	
ocular	O	O	
health	O	O	
.	O	O	
patient	O	O	
was	O	O	
given	O	O	
methylcellulose	O	O	
ophthalmic	O	O	
,	O	O	
one	O	O	
drop	O	O	
in	O	O	
each	O	O	
eye	O	O	
daily	O	O	
.	O	O	
she	O	O	
should	O	O	
follow	O	O	
up	O	O	
in	O	O	
6	O	O	
weeks	O	O	
with	O	O	
the	O	O	
ophthalmology	O	O	
clinic	O	O	
.	O	O	
6	O	O	
.	O	O	
management	O	O	
of	O	O	
depression	O	O	
.	O	O	
patient	O	O	
will	O	O	
be	O	O	
continued	O	O	
on	O	O	
citalopram	O	O	
10	O	O	
mg	O	O	
.	O	O	
keywords	O	O	
:	O	O	
general	O	O	
medicine	O	O	
,	O	O	
hyperthyroidism	O	O	
,	O	O	
diabetes	O	O	
,	O	O	
hypertension	O	O	
,	O	O	
hospital	O	O	
course	O	O	
,	O	O	
thyroid	O	O	
function	O	O	
,	O	O	
tachycardia	O	O	
,	O	O	
pregnancy	O	O	
,	O	O	
